LENDA BARRETT: Open Payments
NPI 1457965501 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 39 payments from 14 companies in 2025. Trend: 2023 $883 · 2024 $1,249 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 5 | $183 |
| AstraZeneca Pharmaceuticals LP | 5 | $163 |
| Calliditas Therapeutics US Inc. | 6 | $163 |
| Novo Nordisk Inc | 2 | $135 |
| Otsuka America Pharmaceutical, Inc. | 4 | $105 |
| AKEBIA THERAPEUTICS INC | 1 | $99 |
| Ardelyx, Inc. | 3 | $77 |
| Apellis Pharmaceuticals, Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
Products named: TARPEYO, Ozempic, JYNARQUE, Vafseo, Filspari, FARXIGA, BREZTRI, IBSRELA.
Industry payments across SC — which companies pay providers there.
